Bridgebio Oncology Therapeutics, Inc.

BBOT·NASDAQ·$8.37Share Price as of 11/2·$670MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/01/25

Disclosures

8-KCurrent report09/08/26 8-KCurrent report08/11/26 8-KCurrent report06/22/26 8-KCurrent report05/12/26 8-KCurrent report04/29/26

Prospectuses and Registrations

POS AMPost-effective amendment09/01/26 S-3Shelf registration09/01/26 424B3Prospectus08/12/26 424B3Prospectus06/22/26 424B3Prospectus05/13/26

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26

Ownership

Form 4Insider transaction10/23/26 Form 4Insider transaction10/05/26 Form 4Insider transaction10/05/26 Form 4Insider transaction10/05/26 Form 4Insider transaction10/05/26

Other

EFFECTRequest for effectiveness09/10/26 EFFECTRequest for effectiveness09/08/26 EFFECTRequest for effectiveness05/04/26 ARSAnnual report to shareholders04/28/26 EFFECTRequest for effectiveness09/10/25